LASP1 and nasopharyngeal carcinoma: Previous studies showed that LASP1 was upregulated in many malignant tumors including nasopharyngeal carcinoma, breast cancer, glioblastoma and colorectal cancer and contributed to tumor proliferation, invasion and metastasis [20–23].